1. Home
  2. AIG vs IQV Comparison

AIG vs IQV Comparison

Compare AIG & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American International Group Inc. New

AIG

American International Group Inc. New

HOLD

Current Price

$79.20

Market Cap

41.7B

Sector

Finance

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$206.73

Market Cap

34.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIG
IQV
Founded
1919
1982
Country
United States
United States
Employees
N/A
93000
Industry
Life Insurance
Biotechnology: Commercial Physical & Biological Resarch
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.7B
34.6B
IPO Year
2006
2013

Fundamental Metrics

Financial Performance
Metric
AIG
IQV
Price
$79.20
$206.73
Analyst Decision
Hold
Strong Buy
Analyst Count
14
16
Target Price
$86.46
$227.13
AVG Volume (30 Days)
3.4M
1.5M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
2.44%
N/A
EPS Growth
350.23
4.67
EPS
1.41
1.61
Revenue
$26,775,000,000.00
$9,739,000,000.00
Revenue This Year
$11.55
$6.77
Revenue Next Year
$5.26
$5.89
P/E Ratio
$56.11
$129.27
Revenue Growth
N/A
41.60
52 Week Low
$71.25
$154.50
52 Week High
$87.35
$247.05

Technical Indicators

Market Signals
Indicator
AIG
IQV
Relative Strength Index (RSI) 58.91 67.75
Support Level $73.37 $206.72
Resistance Level $81.88 $209.48
Average True Range (ATR) 1.80 6.63
MACD 0.43 1.95
Stochastic Oscillator 59.76 92.08

Price Performance

Historical Comparison
AIG
IQV

About AIG American International Group Inc. New

American International Group is one of the largest insurance and financial services firms in the world and has a global footprint. It operates through a wide range of subsidiaries that provide property, casualty, and life insurance. The company recently spun off its life insurance operations (Corebridge), but still retains a minority stake.

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Share on Social Networks: